WELL Health Subsidiary WELLSTAR Closes C$50 Million Financing Transaction Ahead of Planned TSXV Listing

Vancouver, British Columbia--(Newsfile Corp. - July 31, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (" WELL "), a digital health company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce that its subsidiary, WELLSTAR Technologies Corp. (" WELLSTAR "), has closed a financing transaction for aggregate gross proceeds of C$50 million (the " Financing "), consisting of C$36.2 million of gross proceeds for WELLSTAR pursuant to a treasury offering of subscription receipts (the " Treasury Offering ") and C$13.8 million of gross proceeds for an existing shareholder through a secondary offering (the " Secondary Offering "). The Financing was anchored by a large Canadian bank-owned asset manager and included new institutional investors, alongside continued support from existing shareholders, including WELL and certain members of WELL and WELLSTAR management, board of directors, and employees. Including the Treasury Offering, WELLSTAR financings have raised an aggregate of C$162 million in the last 19 months, across treasury and secondary transactions, of which C$148 million represents treasury proceeds to WELLSTAR, including a C$62 million WELLSTAR financing completed in December 2025 and a C$50 WELLSTAR million financing completed in December 2024. Amir Javidan, CEO of WELLSTAR commented, "We are very grateful for the continued support from our investors, both new and existing, throughout this financing process. The response from investors reflects confidence in WELLSTAR's team, our growth strategy, our sustained combination of growth and profitability, and our category leadership in Canadian healthcare technology. We look forward to our trading debut on the TSXV, which we expect in September." The net proceeds available to WELLSTAR from the Treasury Offering will be released upon satisfaction of the escrow release conditions of the subscription receipts, which include the concurrent closing of the previously announced amalgamation (the " Transaction ") of WELLSTAR and 1587818 B.C. Ltd., and will be used by WELLSTAR for potential future acquisitions, AI-related innovation, organic growth initiatives and general corporate purposes. The Transaction, and WELLSTAR's intended listing of the subordinate voting shares of the issuer resulting from the Transaction on the TSX Venture Exchange, is expected to close on or about September 16, 2026. TD Securities Inc., RBC Capital Markets and Stifel Nicolaus Canada Inc. are acting as lead agents, on behalf of a syndicate of agents, in connection with the Treasury Offering. Further details of the Transaction and the terms of the subscription receipts can be found in WELL's July 7, 2026 press release entitled "WELL Health Announces Proposed TSXV Listing and Concurrent Financing for WELLSTAR, One of Canada's Leading Healthcare Software and AI Platforms." WELL HEALTH TECHNOLOGIES CORP. Per: "Hamed Shahbazi" Hamed Shahbazi Chief Executive Officer, Chairman and Director About WELLSTAR WELLSTAR is a leading healthcare technology company dedicated to reshaping healthcare through digital enablement. We provide a comprehensive, holistic solution for healthcare providers across Canada, with over 40% of practitioners currently using our products and services. Our solutions serve primary care and specialist physicians, health systems, and public-sector organizations through a complete suite of AI-enabled offerings, including billing and practice management systems, electronic medical record (EMR) systems, digital health applications, and digital health network solutions. As a majority-owned subsidiary of WELL Health, WELLSTAR continues to drive innovation and transformation in the Canadian healthcare landscape, reducing administrative burden and empowering providers to deliver better patient outcomes through advanced technology solutions. Learn more at wellstar.health . About WELL Health Technologies Corp. WELL Health Technologies Corp. (TSX: WELL) is Canada's largest outpatient healthcare company and a leading provider of technology-enabled healthcare solutions. WELL is building the infrastructure for a healthier Canada, where every patient gets better care, every provider is empowered by AI, and every piece of health data is protected. WELL owns and operates approximately 270 clinics in Canada, supporting more than 5 million annual patient visits. Through its subsidiary WELLSTAR, WELL provides electronic medical records, AI-powered clinical tools, patient engagement platforms and IT management services. WELL provides cybersecurity services through its CYBERWELL subsidiary. WELL is publicly traded on the TSX under the symbol "WELL" and on the OTC Exchange under the symbol "WHTCF". To learn more, please visit: www.well.company . Forward-Looking Statements his news release contains "forward-looking information" within the meaning of applicable Canadian securities